The recording and slides are available now for the May 4 “Toxicogenomics and Its Relevance to Support Hazard Assessment” session, the latest in the SOT FDA Colloquia on Emerging Toxicological Science: Challenges in Food and Ingredient Safety series.
Co-chaired by Xiugong Gao and me, the session reviews the state-of-the-science in toxicogenomics and its relevance to support hazard assessment of chemicals. Included are recent technological innovations in toxicogenomics, followed by case studies demonstrating the application of toxicogenomics in risk assessment and toxicity prediction of chemicals related to food and cosmetics. The colloquium discusses current challenges facing regulatory application and provides perspectives on future directions of toxicogenomics.
- Welcome from FDA, Steven M. Musser, Deputy Director of Scientific Operations, US FDA/CFSAN, College Park, MD
- Welcome from SOT, Michael Aschner, SOT President, Albert Einstein College of Medicine, Bronx, NY
- Overview and Speaker Introductions, Stephen Edwards, Colloquium Co-Chair, RTI International, Research Triangle Park, NC
- Overview of Toxicogenomics and Its Contribution to Toxicological Science, Carole L. Yauk, University of Ottawa/Health Canada, Ottawa, ON, Canada
- High-Throughput Transcriptomics for Chemical Bioactivity Screening and Tiered Hazard Evaluation, Joshua A. Harrill, US EPA, Research Triangle Park, NC
- Toxicogenomics to Support Hazard Assessment, Russell Thomas, US EPA, Research Triangle Park, NC
- Application of Toxicogenomics in Toxicity Assessment of Chemicals in Food and Cosmetics, Jorge Naciff, Procter & Gamble Company, Mason, OH
Materials from the other 26 sessions also can be accessed via the SOT Video Library. An extensive range of topics is available, including recent sessions on arsenic and children’s health, toxicology of nanoparticles, new plant-based foods, and integrated approaches to testing and assessment.
Plans are underway for two new topics for the 2022–2023 year.